- Home
- EZGO vs CYCC Comparison
EZGO vs CYCC Comparison
Compare EZGO & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EZGO
- CYCC
- Stock Information
- Founded
- EZGO 2014
- CYCC 1992
- Country
- EZGO China
- CYCC United States
- Employees
- EZGO N/A
- CYCC N/A
- Industry
- EZGO Motor Vehicles
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- EZGO Consumer Discretionary
- CYCC Health Care
- Exchange
- EZGO Nasdaq
- CYCC Nasdaq
- Market Cap
- EZGO 2.5M
- CYCC 2.3M
- IPO Year
- EZGO 2021
- CYCC N/A
- Fundamental
- Price
- EZGO $0.74
- CYCC $0.34
- Analyst Decision
- EZGO
- CYCC Buy
- Analyst Count
- EZGO 0
- CYCC 2
- Target Price
- EZGO N/A
- CYCC $11.00
- AVG Volume (30 Days)
- EZGO 81.2K
- CYCC 431.0K
- Earning Date
- EZGO 01-24-2025
- CYCC 11-12-2024
- Dividend Yield
- EZGO N/A
- CYCC N/A
- EPS Growth
- EZGO N/A
- CYCC N/A
- EPS
- EZGO N/A
- CYCC N/A
- Revenue
- EZGO $19,334,254.00
- CYCC $74,000.00
- Revenue This Year
- EZGO N/A
- CYCC N/A
- Revenue Next Year
- EZGO N/A
- CYCC $88.68
- P/E Ratio
- EZGO N/A
- CYCC N/A
- Revenue Growth
- EZGO 14.03
- CYCC N/A
- 52 Week Low
- EZGO $0.71
- CYCC $0.32
- 52 Week High
- EZGO $4.72
- CYCC $4.00
- Technical
- Relative Strength Index (RSI)
- EZGO 27.46
- CYCC 37.88
- Support Level
- EZGO $0.71
- CYCC $0.33
- Resistance Level
- EZGO $0.90
- CYCC $0.42
- Average True Range (ATR)
- EZGO 0.07
- CYCC 0.04
- MACD
- EZGO -0.01
- CYCC 0.01
- Stochastic Oscillator
- EZGO 2.44
- CYCC 8.21
About EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.